| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jun―03 |
Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease |
Meiling Jin, Lijie Ma, Yuqing Yuan, Kaiyi Zhu, Zhaohui Tong, Qianmei Sun |
| 2 |
[GO] |
2025―Dez―19 |
Alterations of the oral microbiome in patients reinfected with SARS-CoV-2 omicron variants |
Benchen Rao, Yongjian Zhou, Tong Ren, Hongxia Liang, Lei Li, Yakun Xu, et al. (+12) Haiyu Wang, Xiaoping Wang, Xiaoli Ni, Xiaoning Wang, Hanmeng Liu, Xiaoli Jin, Qiaoxia Chen, Xuemei Wang, Yawen Zou, Ying Sun, Zhigang Ren, Zujiang Yu |
| 3 |
[GO] |
2025―Apr―24 |
Cover Picture: Antiviral effectiveness and safety of azvudine in hospitalized SARS-CoV-2 patients with pre-existing chronic respiratory diseases: A multicenter, retrospective cohort study (View 2/2025) |
Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, et al. (+12) Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren |
| 4 |
[GO] |
2025―Apr―09 |
The effectiveness and safety of azvudine treatment in COVID-19 patients with kidney disease based on a multicenter retrospective cohort study |
Bo Yu, Mengzhao Yang, Jia Yu, Daming Wang, Hong Luo, Ming Cheng, et al. (+8) Shixi Zhang, Guotao Li, Ling Wang, Guowu Qian, Donghua Zhang, Silin Li, Zhigang Ren, Quancheng Kan |
| 5 |
[GO] |
2025―Feb―06 |
Antiviral effectiveness and safety of azvudine in hospitalized SARS-CoV-2 patients with pre-existing chronic respiratory diseases: A multicenter, retrospective cohort study |
Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, et al. (+12) Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren |
| 6 |
[GO] |
2024―Jun―19 |
Cover Picture: MALDI-TOF MS analysis of nasal swabs for the characterization of patients infected with SARS-CoV-2 Omicron (View 3/2024) |
Rui Song, Dandan Li, Xiaohua Hao, Qian Lyu, Qingwei Ma, Xiaoyou Chen, Liang Qiao |
| 7 |
[GO] |
2024―Mai―16 |
MALDI-TOF MS analysis of nasal swabs for the characterization of patients infected with SARS-CoV-2 Omicron |
Rui Song, Dandan Li, Xiaohua Hao, Qian Lyu, Qingwei Ma, Xiaoyou Chen, Liang Qiao |
| 8 |
[GO] |
2022―Nov―29 |
Back Cover: Wearable respiratory sensors for COVID-19 monitoring (View 5/2022) |
Guorui Chen, Sophia Shen, Trinny Tat, Xun Zhao, Yihao Zhou, Yunsheng Fang, Jun Chen |
| 9 |
[GO] |
2022―Nov―01 |
Wearable respiratory sensors for COVID-19 monitoring |
Guorui Chen, Sophia Shen, Trinny Tat, Xun Zhao, Yihao Zhou, Yunsheng Fang, Jun Chen |
| 10 |
[GO] |
2022―Jul―25 |
Back Cover: Detection, prevention and treatment of COVID-19 and opportunities for nanobiotechnology (View 4/2022) |
Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao |
| 11 |
[GO] |
2022―Jul―25 |
Cover Picture: Nanoantidote for repression of acidosis pH promoting COVID-19 infection (View 4/2022) |
Qidong Liu, Huitong Ruan, Zhihao Sheng, Xiaoru Sun, Siguang Li, Wenguo Cui, Cheng Li |
| 12 |
[GO] |
2022―Jul―20 |
Progress in COVID research and developments during pandemic |
Sudheesh K. Shukla, Santanu Patra, Trupti R. Das, Dharmesh Kumar, Anshuman Mishra, Ashutosh Tiwari |
| 13 |
[GO] |
2022―Mai―02 |
Nanoantidote for repression of acidosis pH promoting COVID-19 infection |
Qidong Liu, Huitong Ruan, Zhihao Sheng, Xiaoru Sun, Siguang Li, Wenguo Cui, Cheng Li |
| 14 |
[GO] |
2022―Mrz―21 |
Back Cover: Therapeutic antibodies under development for SARS-CoV-2 (View 2/2022) |
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, et al. (+2) Changhai Lei, Shi Hu |
| 15 |
[GO] |
2022―Mrz―15 |
Detection, prevention and treatment of COVID-19 and opportunities for nanobiotechnology |
Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao |
| 16 |
[GO] |
2022―Jan―31 |
Portable and visual assays for the detection of SARS-CoV-2 |
Yufan Zhang, Dan Ding |
| 17 |
[GO] |
2022―Jan―31 |
Inside Front Cover: Portable and visual assays for the detection of SARS-CoV-2 (View 1/2022) |
Yufan Zhang, Dan Ding |
| 18 |
[GO] |
2021―Jul―12 |
Therapeutic antibodies under development for SARS-CoV-2 |
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, et al. (+2) Changhai Lei, Shi Hu |
| 19 |
[GO] |
2021―Jun―18 |
Biodiagnostics in an era of global pandemics-From biosensing materials to data management |
Yoav Y. Broza, Hossam Haick |
| 20 |
[GO] |
2021―Jun―17 |
Frontispiece: Exosome therapeutics for COVID-19 and respiratory viruses (View 3/2021) |
Kristen D. Popowski, Phuong-Uyen C. Dinh, Arianna George, Halle Lutz, Ke Cheng |
| 21 |
[GO] |
2021―Jun―17 |
Inside Back Cover: Nano-therapeutic strategies to target coronavirus (View 3/2021) |
Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer |
| 22 |
[GO] |
2021―Mai―06 |
Advances of nanomaterials-based strategies for fighting against COVID-19 |
Chunxi Zeng, Xucheng Hou, Margaret Bohmer, Yizhou Dong |
| 23 |
[GO] |
2021―Apr―08 |
Cover Picture: Applications of digital PCR in COVID-19 pandemic (View 2/2021) |
Chianru Tan, Dongdong Fan, Nan Wang, Fang Wang, Bo Wang, Lingxiang Zhu, Yong Guo |
| 24 |
[GO] |
2021―Mrz―09 |
Nano-therapeutic strategies to target coronavirus |
Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer |
| 25 |
[GO] |
2021―Jan―31 |
Exosome therapeutics for COVID-19 and respiratory viruses |
Kristen D. Popowski, Phuong-Uyen C. Dinh, Arianna George, Halle Lutz, Ke Cheng |
| 26 |
[GO] |
2021―Jan―01 |
Applications of digital PCR in COVID-19 pandemic |
Chianru Tan, Dongdong Fan, Nan Wang, Fang Wang, Bo Wang, Lingxiang Zhu, Yong Guo |
| 27 |
[GO] |
2020―Sep―25 |
Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID-19 |
Sydney Kusumoputro, Shannon Tseng, Jonathan Tse, Christian Au, Candice Lau, Xiang Wang, Tian Xia |
| 28 |
[GO] |
2020―Mrz―23 |
Promising methods for detection of novel coronavirus SARS-CoV-2 |
Ran Liu, Aisi Fu, Zixin Deng, Yan Li, Tiangang Liu |
|
